You are here

Post Reproductive Health
Share

Post Reproductive Health

Published in Association with British Menopause Society
The Journal of The British Menopause Society

Editors
Heather Currie Dumfries & Galloway Royal Infirmary, UK
Edward Morris Norfolk & Norwich University Hospital, UK
Associate Editor
Tony Mander University of Manchester, UK
News Editor
Simon Brown Medical Journalist, UK
Trainee Editor
Paul Simpson Norfolk and Norwich University Hospital, UK
Social Media Editor
Hannah Short West Suffolk NHS Foundation Trust, UK

Other Titles in:
Obstetrics & Gynecology

eISSN: 20533705 | ISSN: 20533691 | Current volume: 23 | Current issue: 3 Frequency: Quarterly

Post Reproductive Health (formerly Menopause International) is a MEDLINE indexed, peer reviewed source of news, research and opinion. Aimed at all those involved in the field of post reproductive health study and treatment, it is a vital resource for all practitioners and researchers. As the official journal of the British Menopause Society (BMS), Post Reproductive Health has a broad scope, tackling all the issues in this field, including the current controversies surrounding postmenopausal health and an ageing and expanding female population. Initially this journal will concentrate on the key areas of menopause, sexual health, urogynaecology, metabolic bone disease, cancer diagnosis and treatment, recovering from cancer, cardiovascular disease, cognition, prescribing, use of new hormone therapies, psychology, the science of ageing, sociology, economics, and quality of life. However as a progressive and innovative journal the Editors are always willing to consider other areas relevant to this rapidly expanding area of healthcare. 

This journal is a member of the Committee on Publication Ethics (COPE)


 

Post Reproductive Health (formerly Menopause International) is a MEDLINE indexed, peer reviewed source of news, research and opinion. Aimed at all those involved in the field of post reproductive health study and treatment, it is a vital resource for all practitioners and researchers. As the official journal of the British Menopause Society (BMS), Post Reproductive Health has a broad scope, tackling all the issues in this field, including the current controversies surrounding postmenopausal health and an ageing and expanding female population. Initially this journal will concentrate on the key areas of menopause, sexual health, urogynaecology, metabolic bone disease, cancer diagnosis and treatment, recovering from cancer, cardiovascular disease, cognition, prescribing, use of new hormone therapies, psychology, the science of ageing, sociology, economics, and quality of life. However as a progressive and innovative journal the Editors are always willing to consider other areas relevant to this rapidly expanding area of healthcare.

Editorial Board
Kathy Abernethy London North West Healthcare NHS Trust, UK
Oscar Gonzalez The Hospital Clinico de la Universidad de Chile, Chile
Victor Henderson Stanford University, USA
Tim Hillard Hospital NHS Foundation Trust, UK
Nick Manassiev Goodrest Croft Surgery, UK
Jo Marsden Kings College Hospital, UK
Rossella E. Nappi IRCCS S. Matteo Foundation and University of Pavia, Italy
Mary Olliver University of Ontago, New Zealand
Santiago Palacios Palacios Institute of Woman's Health, Spain
Joan Pitkin Northwick Park Hospital, UK
Andrea Rapkin University of California Los Angeles, USA
Colette Smith University College London, UK
John Stevenson Imperial College London, UK
  • ArticleFirst
  • EBSCO: CINAHL Plus
  • EBSCO: CINAHL Plus with Full Text
  • EBSCO: Gender Studies Database
  • EBSCO: Sales & Marketing Source
  • EBSCOhost: Current Abstracts
  • Electronic Collections Online
  • Elsevier: EMBASE
  • MEDLINE
  • PubMed: MEDLINE
  • Reactions Weekly
  • Scopus
  • Manuscript Submission Guidelines: Post Reproductive Health

    This Journal is a member of the Committee on Publication Ethics.

    This Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).

    Please read the guidelines below then visit the Journal’s submission site http://mc.manuscriptcentral.com/prh to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned.

    Only manuscripts of sufficient quality that meet the aims and scope of Post Reproductive Health will be reviewed.

    There are no fees payable to submit or publish in this journal.

    As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you.

    1. What do we publish?
      1.1 Aims & Scope
      1.2 Article types
      1.3 Writing your paper
    2. Editorial policies
      2.1 Peer review policy
      2.2 Declarations
      2.3 Authorship
      2.4 Acknowledgements
      2.5 Funding
      2.6 Declaration of conflicting interests
      2.7 Research ethics and patient consent
      2.8 Clinical trials
      2.9 Reporting guidelines
      2.10 Data
      2.11 Guarantor 
    3. Publishing policies
      3.1 Publication ethics
      3.2 Contributor's publishing agreement
      3.3 Open access and author archiving
    4. Preparing your manuscript
      4.1 Formatting
      4.2 Artwork, figures and other graphics
      4.3 Supplementary material
      4.4 Reference style
      4.5 English language editing services
    5. Submitting your manuscript
      5.1 ORCID
      5.2 Information required for completing your submission
      5.3 Permissions
    6. On acceptance and publication
      6.1 SAGE Production
      6.2 Online First publication
      6.3 Access to your published article
      6.4 Promoting your article
    7. Further information

    1. What do we publish?

    1.1 Aims & Scope

    Before submitting your manuscript to Post Reproductive Health, please ensure you have read the Aims & Scope.

    1.2 Article Types

    Please note that all word counts include the abstract, acknowledgements and references. Please take care not to exceed the word limit.

    Declarations
    Please note all manuscripts should be accompanied by a separate document entitled ‘Declarations’. This should be submitted under the file designation ‘Declarations’. This must include each of the below headings with the corresponding information. Please note that manuscripts which do not include these Declarations will be returned. These headings will be published at the end of every accepted manuscript, where one of these headings is not applicable please indicate as such under the heading.  Please see section 2.2 for additional information regarding declarations. 

    DECLARATIONS
    Conflicting interests
    Funding 
    Ethical approval
    Guarantor 
    Contributorship
    Acknowledgements

    Original articles: a full-length report of original basic or clinical investigation (2,000–3,000 words, up to 30 references). A structured abstract of no more than 250 words with the following sections is required: Objective, Study design, Main outcome measures, Results, Conclusions. The rest of the paper should be structured in conventional style: Introduction, Methods, Results, Discussion, Acknowledgements, References.

    The Introduction should describe the questions addressed by the report and must state the objective of the research. The literature review should be relevant, but not detailed. The Methods section should describe the research methodology in sufficient detail that others could reasonably be expected to be able to duplicate the work. However, if the methodology has been previously published, the appropriate reference should be cited, and a full description is not required. Methods of statistical analysis should be identified and, when appropriate, the basis for their selection stated. Statistical software programs used should be cited in the text. P values should be expressed to no more than three decimal places. Reports in which statistical difference is lacking must provide some indication of the study's power to detect such differences, and this information must be included in the abstract. The Results section should present the findings in appropriate detail. Tables and figures may be used, but duplication between text and tables or figures is to be avoided. The Discussion section should be used to critically appraise the implications of the findings and to compare them with those of other studies. Repetition of the results section should be avoided.

    Submission of randomized controlled trials requires inclusion of a checklist and flowchart in accordance with the CONSORT guidelines and the registration number of the trial and the name of the trial registry.

    Review articles: a comprehensive review of prior publications relating to an important clinical subject (2,000–3,000 words and 30–50 references). An unstructured abstract of no more than 250 words is required. The Introduction should indicate why the topic is important and should state the specific objective of the review. The Conclusion should include the clinical implications and observations regarding the need for additional research. The review should include a summary of Practice Points and, if applicable, Auditable Standards. Systematic reviews should follow the QUOROM guidelines. Meta-analysis of observational studies should follow the MOOSE guidelines.

    Short reports: must not exceed 600 words with no more than one table or illustration and five references. An unstructured abstract of no more than 100 words is required. The text should be structured in four parts: Introduction, Methods, Results, Discussion.

    Research in progress: a description of the design of ongoing important clinical trials. Suggested length is no more than 3,000 words and 30 references. An unstructured abstract of no more than 250 words is required.

    Case reports: a brief description of up to three cases of a particular condition that is unusual and instructive. Suggested length is no more than 1,000 words and 10 references. An unstructured abstract of no more than 100 words is required.

    Clinical practice: a description of methods of diagnosis and treatment. Suggested length is 500–1,000 words and 5–10 references. An unstructured abstract of no more than 100 words is required.

    Practice observed: an article for light reading, usually a case report, pertinent to the discipline. Wit and satire may be appropriate for this section. Suggested length is 250 words.

    News and views: a short dissertation expressing opinions, experiences or a statement regarding a topic of current interest of no more than 500 words in length with no more than five references.

    Letters to the Editors/Correspondence: a question or challenge to an article published recently in Post Reproductive Health  . Letters must be received within six weeks of publication of the article to which they refer.

    As I see it: a commentary on a topic which may be controversial, confusing or just of personal to the author.

    Book review: an independent review of a recent book relevant to postmenopausal health. This can be a traditional medical textbook or a book from the lay press that is considered useful for the readership of Post Reproductive Health . These may be invited reviews, but the Editors are happy to receive uninvited submissions.

    1.3 Writing your paper

    The SAGE Author Gateway has some general advice and on how to get published, plus links to further resources.

    1.3.1 Make your article discoverable

    When writing up your paper, think about how you can make it discoverable. The title, keywords and abstract are key to ensuring readers find your article through search engines such as Google. For information and guidance on how best to title your article, write your abstract and select your keywords, have a look at this page on the Gateway: How to Help Readers Find Your Article Online.

    Back to top

    2. Editorial policies

    2.1 Peer review policy

    All manuscripts submitted for publication undergo peer review. Post Reproductive Health operates a single-blind reviewing policy in which the reviewer's name is always concealed from the submitting author. All contributions to Post Reproductive Health will be considered for publication on the understanding that they are not under consideration/accepted for publication or already published elsewhere. Referees are chosen for their knowledge of the topic. If a manuscript is considered not to be acceptable as submitted, but could be made acceptable with revision, it will be returned to the corresponding author with a detailed appraisal. This action should not be interpreted as any sort of commitment to accept the paper. Revisions must be received within 30 days. A letter replying to the referees' points, item by item, must be included, together with a copy of the revised manuscript highlighting the changes. The revised manuscript is evaluated by the Editors, and may be sent back to the referees. The manuscript may be accepted for publication if the revisions are considered to answer all concerns. The final decision on acceptance or rejection will remain with the Editors.

    As part of the submission process you will be asked to provide the names of peers who could be called upon to review your manuscript. Recommended reviewers should be experts in their fields and should be able to provide an objective assessment of the manuscript. Please be aware of any conflicts of interest when recommending reviewers. Examples of conflicts of interest include (but are not limited to) the below: 

      • The reviewer should have no prior knowledge of your submission
      • The reviewer should not have recently collaborated with any of the authors
      • Reviewer nominees from the same institution as any of the authors are not permitted

    Please note that the Editors are not obliged to invite any recommended/opposed reviewers to assess your manuscript.

    2.2 Declarations

    Please note all manuscripts should be accompanied by a separate document entitled ‘Declarations’. This should be submitted under the file designation ‘Declarations’. This must include each of the below headings with the corresponding information. Please note that manuscripts which do not include these Declarations will be returned. These headings will be published at the end of every accepted manuscript, where one of these headings is not applicable please indicate as such under the heading. 

    DECLARATIONS

    Conflicting interests

    Funding

    Ethical approval

    Guarantor

    Contributorship

    Acknowledgements

    Please see the below example of a completed declarations section:

    DECLARATIONS

    Conflicting interests: MS is an employee of XXX. BF has received grants from XXX.

    Funding: This work was supported by the Medical Research Council [grant number XXX].

    Ethical approval: The ethics committee of  XXXX approved this study (REC number: XXXX)

    Guarantor: BF

    Contributorship: BF and NP researched literature and conceived the study. MS was involved in protocol development, gaining ethical approval, patient recruitment and data analysis. BF wrote the first draft of the manuscript. All authors reviewed and edited the manuscript and approved the final version of the manuscript

    Acknowledgements: We would like to thank XXX XXXX for his assistance and guidance in this research.

    Please read the following information carefully for additional information regarding these declarations.

    2.3 Authorship

    Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors.

    The list of authors should include all those who can legitimately claim authorship. This is all those who:

      • Made a substantial contribution to the concept or design of the work; or acquisition, analysis or interpretation of data,
      • Drafted the article or revised it critically for important intellectual content,
      • Approved the version to be published,
      • Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.

    Authors should meet the conditions of all of the points above. When a large, multicentre group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship.

    Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship, although all contributors who do not meet the criteria for authorship should be listed in the Acknowledgments section. Please refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on authorship.

    2.4 Acknowledgements

    All contributors who do not meet the criteria for authorship should be listed in an Acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, or a department chair who provided only general support.

    2.4.1 Writing assistance

    Individuals who provided writing assistance, e.g. from a specialist communications company, do not qualify as authors and so should be included in the Acknowledgements section. Authors must disclose any writing assistance – including the individual’s name, company and level of input – and identify the entity that paid for this assistance”).

    It is not necessary to disclose use of language polishing services.

    Any acknowledgements should appear first at the end of your article prior to your Declaration of Conflicting Interests (if applicable), any notes and your References.

    2.5 Funding

    Post Reproductive Health requires all authors to acknowledge their funding in a consistent fashion under a separate heading.  Please visit the Funding Acknowledgements page on the SAGE Journal Author Gateway to confirm the format of the acknowledgment text in the event of funding, or state that: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

    2.6 Declaration of conflicting interests

    It is the policy of Post Reproductive Health to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles.

    Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of your manuscript, after any acknowledgements and prior to the references. If no conflict exists, please state that ‘The Author(s) declare(s) that there is no conflict of interest’. For guidance on conflict of interest statements, please see the ICMJE recommendations here.

    2.7 Research ethics and patient consent

    Medical research involving human subjects must be conducted according to the World Medical Association Declaration of Helsinki.

    Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers reporting animal and/or human studies must state in the methods section that the relevant Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number.

    For research articles, authors are also required to state in the methods section whether participants provided informed consent and whether the consent was written or verbal.

    Information on informed consent to report individual cases or case series should be included in the manuscript text. A statement is required regarding whether written informed consent for patient information and images to be published was provided by the patient(s) or a legally authorized representative.

    Please also refer to the ICMJE Recommendations for the Protection of Research Participants.

    All research involving animals submitted for publication must be approved by an ethics committee with oversight of the facility in which the studies were conducted. The journal has adopted the Consensus Author Guidelines on Animal Ethics and Welfare for Veterinary Journals published by the International Association of Veterinary Editors

    2.8 Clinical trials

    Post Reproductive Health conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.

    2.9 Reporting guidelines

    The relevant EQUATOR Network reporting guidelines should be followed depending on the type of study. For example, all randomized controlled trials submitted for publication should include a completed CONSORT flow chart as a cited figure and the completed CONSORT checklist should be uploaded with your submission as a supplementary file. Systematic reviews and meta-analyses should include the completed PRISMA flow chart as a cited figure and the completed PRISMA checklist should be uploaded with your submission as a supplementary file. The EQUATOR wizard can help you identify the appropriate guideline.

    Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives.

    2.10 Data

    SAGE acknowledges the importance of research data availability as an integral part of the research and verification process for academic journal articles.

    Post Reproductive Health requests all authors submitting any primary data used in their research articles alongside their article submissions to be published in the online version of the journal, or provide detailed information in their articles on how the data can be obtained. This information should include links to third-party data repositories or detailed contact information for third-party data sources. Data available only on an author-maintained website will need to be loaded onto either the journal’s platform or a third-party platform to ensure continuing accessibility. Examples of data types include but are not limited to statistical data files, replication code, text files, audio files, images, videos, appendices, and additional charts and graphs necessary to understand the original research. The editors may consider limited embargoes on proprietary data. The editors can also grant exceptions for data that cannot legally or ethically be released. All data submitted should comply with Institutional or Ethical Review Board requirements and applicable government regulations. For further information, please contact the editorial office at prheditorial@sagepub.co.uk

    2.11 Guarantor

    The Guarantor is the person willing to take full responsibility for the article, including for the accuracy and appropriateness of the reference list. This will often be the most senior member of the research group and is commonly also the author for correspondence. Please state this person’s name as initials.

    Back to top

    3. Publishing Policies

    3.1 Publication ethics

    SAGE is committed to upholding the integrity of the academic record. We encourage authors to refer to the Committee on Publication Ethics’ International Standards for Authors and view the Publication Ethics page on the SAGE Author Gateway.

    3.1.1 Plagiarism

    Post Reproductive Health and SAGE take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of published articles. Equally, we seek to protect the reputation of the journal against malpractice. Submitted articles may be checked with duplication-checking software. Where an article, for example, is found to have plagiarised other work or included third-party copyright material without permission or with insufficient acknowledgement, or where the authorship of the article is contested, we reserve the right to take action including, but not limited to: publishing an erratum or corrigendum (correction); retracting the article; taking up the matter with the head of department or dean of the author's institution and/or relevant academic bodies or societies; or taking appropriate legal action.

    3.1.2 Prior publication

    If material has been previously published it is not generally acceptable for publication in a SAGE journal. However, there are certain circumstances where previously published material can be considered for publication. Please refer to the guidance on the SAGE Author Gateway or if in doubt, contact the Editor at the address given below.

    3.2 Contributor's publishing agreement

    Before publication, SAGE requires the author as the rights holder to sign a Journal Contributor’s Publishing Agreement. SAGE’s Journal Contributor’s Publishing Agreement is an exclusive licence agreement which means that the author retains copyright in the work but grants SAGE the sole and exclusive right and licence to publish for the full legal term of copyright. Exceptions may exist where an assignment of copyright is required or preferred by a proprietor other than SAGE. In this case copyright in the work will be assigned from the author to the society. For more information please visit the SAGE Author Gateway.

    3.3 Open access and author archiving

    Post Reproductive Health offers optional open access publishing via the SAGE Choice programme. For more information please visit the SAGE Choice website. For information on funding body compliance, and depositing your article in repositories, please visit SAGE Publishing Policies on our Journal Author Gateway.

    Back to top

    4. Preparing your manuscript for submission

    4.1 Formatting

    The preferred format for your manuscript is Word. LaTeX files are also accepted. Word and (La)Tex templates are available on the Manuscript Submission Guidelines page of our Author Gateway.

    4.2 Artwork, figures and other graphics

    For guidance on the preparation of illustrations, pictures and graphs in electronic format, please visit SAGE’s Manuscript Submission Guidelines.  

    Figures supplied in colour will appear in colour online regardless of whether or not these illustrations are reproduced in colour in the printed version. For specifically requested colour reproduction in print, you will receive information regarding the costs from SAGE after receipt of your accepted article.

    Tables
    Tables should not duplicate information given in the text. The tables feature of the word processor should be used to prepare them. They should be numbered in the order in which they are referred to in the text and appear on separate pages at the end of the typescript. A brief title should be placed above each table.

    Figures
    All figures should be numbered in the order in which they are mentioned in the text. All figures must be accompanied by a figure legend. If figures are supplied in separate files, the figure legends must all be listed at the end of the main text file.
    Line drawings should be produced electronically and clearly labelled using a sans serif font such as Arial. Graphs may be supplied as Excel spreadsheets (one per sheet). Other line drawings should be supplied in a suitable vector graphic file format (e.g. .eps).  

    All photographic images should be submitted in camera-ready form (i.e. with all extraneous areas removed), and where necessary, magnification should be shown using a scale marker. Photographic images must be supplied at high resolution, preferably 600 dpi. Images supplied at less than 300 dpi are unsuitable for print and will delay publication. The preferred file format is .tif.

    4.3 Supplementary material

    This journal is able to host additional materials online (e.g. datasets, podcasts, videos, images etc) alongside the full-text of the article. For more information please refer to our guidelines on submitting supplementary files.

    4.4 Reference style

    Post Reproductive Health adheres to the SAGE Vancouver reference style. View the SAGE Vancouver guidelines to ensure your manuscript conforms to this reference style.

    If you use EndNote to manage references, you can download the SAGE Vancouver EndNote output file.

    4.5 English language editing services

    Authors seeking assistance with English language editing, translation, or figure and manuscript formatting to fit the journal’s specifications should consider using SAGE Language Services. Visit SAGE Language Services on our Journal Author Gateway for further information.

    Back to top

    5. Submitting your manuscript

    Post Reproductive Health is hosted on SAGE Track, a web based online submission and peer review system powered by ScholarOne™ Manuscripts. Visit http://mc.manuscriptcentral.com/prh to login and submit your article online.

    IMPORTANT: Please check whether you already have an account in the system before trying to create a new one. If you have reviewed or authored for the journal in the past year it is likely that you will have had an account created.  For further guidance on submitting your manuscript online please visit ScholarOne Online Help.

    5.1 ORCID

    As part of our commitment to ensuring an ethical, transparent and fair peer review process SAGE is a supporting member of ORCID, the Open Researcher and Contributor ID. ORCID provides a persistent digital identifier that distinguishes researchers from every other researcher and, through integration in key research workflows such as manuscript and grant submission, supports automated linkages between researchers and their professional activities ensuring that their work is recognised.

    We encourage all authors to add their ORCIDs to their SAGE Track accounts and include their ORCIDs as part of the submission process. If you don’t already have one you can create one here.

    5.2 Information required for completing your submission

    You will be asked to provide contact details and academic affiliations for all co-authors via the submission system and identify who is to be the corresponding author. These details must match what appears on your manuscript. At this stage please ensure you have included all the required statements and declarations and uploaded any additional supplementary files (including reporting guidelines where relevant).

    5.3 Permissions

    Please also ensure that you have obtained any necessary permission from copyright holders for reproducing any illustrations, tables, figures or lengthy quotations previously published elsewhere. For further information including guidance on fair dealing for criticism and review, please see the Copyright and Permissions page on the SAGE Author Gateway.

    Back to top

    6. On acceptance and publication

    6.1 SAGE Production

    Your SAGE Production Editor will keep you informed as to your article’s progress throughout the production process. Proofs will be sent by PDF to the corresponding author and should be returned promptly.  Authors are reminded to check their proofs carefully to confirm that all author information, including names, affiliations, sequence and contact details are correct, and that Funding and Conflict of Interest statements, if any, are accurate. Please note that if there are any changes to the author list at this stage all authors will be required to complete and sign a form authorising the change.

    6.2 Online First publication

    Online First allows final articles (completed and approved articles awaiting assignment to a future issue) to be published online prior to their inclusion in a journal issue, which significantly reduces the lead time between submission and publication. Visit the SAGE Journals help page for more details, including how to cite Online First articles.

    6.3 Access to your published article

    SAGE provides authors with online access to their final article.

    6.4 Promoting your article

    Publication is not the end of the process! You can help disseminate your paper and ensure it is as widely read and cited as possible. The SAGE Author Gateway has numerous resources to help you promote your work. Visit the Promote Your Article page on the Gateway for tips and advice. In addition, SAGE is partnered with Kudos, a free service that allows authors to explain, enrich, share, and measure the impact of their article. Find out how to maximise your article’s impact with Kudos

    Back to top

    7. Further information

    Any correspondence, queries or additional requests for information on the manuscript submission process should be sent to the Post Reproductive Health editorial office as follows:

    prheditorial@sagepub.co.uk 

    For institutional and personal subscriptions, and subscription renewals please contact sales@portland-services.com

    Individual Subscription, Combined (Print & E-access)


    Institutional Backfile Purchase, E-access (Content through 1998)


    Institutional Subscription, E-access


    Institutional Subscription, Combined (Print & E-access)


    Institutional Subscription & Backfile Lease, E-access Plus Backfile (All Online Content)


    Institutional Subscription & Backfile Lease, Combined Plus Backfile (Current Volume Print & All Online Content)


    Individual, Single Print Issue


    Institutional, Single Print Issue